Skip to main content
. Author manuscript; available in PMC: 2020 Oct 23.
Published in final edited form as: N Engl J Med. 2020 Mar 30;382(17):1608–1618. doi: 10.1056/NEJMoa1915925

Table 1.

Characteristics of the Patients at Baseline*.

Characteristic Invasive Strategy (N = 388) Conservative Strategy (N = 389) All Patients (N = 777)
Median age (IQR) — yr 62 (55–69) 64 (56–70) 63 (55–70)
Male sex — no. (%) 268 (69.1) 267 (68.6) 535 (68.9)
Race — no./total no. (%)
 White 244/373 (65.4) 237/374 (63.4) 481/747 (64.4)
 Black 33/373 (8.8) 30/374 (8.0) 63/747 (8.4)
 Asian 91/373 (24.4) 100/374 (26.7) 191/747 (25.6)
 Multiple races 5/373 (1.3) 7/374 (1.9) 12/747 (1.6)
Severity of ischemia — no./total no. (%)
 Moderate 242/387 (62.5) 234/388 (60.3) 476/775 (61.4)
 Severe 141/387 (36.4) 152/388 (39.2) 293/775 (37.8)
Risk factor — no./total no. (%)
 Hypertension 349/386 (90.4) 362/387 (93.5) 711/773 (92.0)
 Diabetes 226/388 (58.2) 218/389 (56.0) 444/777 (57.1)
 Current smoker 46/388 (11.9) 38/389 (9.8) 84/777 (10.8)
 Prior myocardial infarction 62/387 (16.0) 71/389 (18.3) 133/776 (17.1)
 Prior heart failure 65/388 (16.8) 70/389 (18.0) 135/777 (17.4)
 Prior stroke 36/388 (9.3) 32/389 (8.2) 68/777 (8.8)
 Peripheral-artery disease 25/388 (6.4) 23/389 (5.9) 48/777 (6.2)
Previous intervention — no. (%)
 PCI 74 (19.1) 72 (18.5) 146 (18.8)
 CABG 14 (3.6) 14 (3.6) 28 (3.6)
Median left ventricular ejection fraction (IQR) — % 58 (50–63) 58 (50–64) 58 (50–64)
Renal transplantation — no./total no. (%)
 History of procedure 9/388 (2.3) 15/389 (3.9) 24/777 (3.1)
 On waiting list 37/358 (10.3) 57/366 (15.6) 94/724 (13.0)
Dialysis
 With end-stage renal disease — no. (%) 198 (51.0) 217 (55.8) 415 (53.4)
 Median duration (IQR) — yr 3 (1–6) 2 (1–4) 2 (1–5)
Type of dialysis — no./total no. (%)
  Hemodialysis 162/196 (82.7) 182/215 (84.7) 344/411 (83.7)
  Peritoneal dialysis 32/196 (16.3) 28/215 (13.0) 60/411 (14.6)
Estimated GFR among those not receiving dialysis
 Median (IQR) — ml/min/1.73 m2 23 (16–27) 23 (17–27) 23 (17–27)
Distribution — no./total no. (%)
  <15 28/190 (14.7) 23/172 (13.4) 51/362 (14.1)
  15 to <30 162/190 (85.3) 149/172 (86.6) 311/362 (85.9)
Seattle Angina Questionnaire
 Median summary score (IQR) 78 (60–94) 79 (64–92) 79 (63–94)
 Median angina frequency score (IQR) 90 (80–100) 90 (80–100) 90 (80–100)
Distribution — no./total no. (%)
   Daily or weekly angina 43/358 (12.0) 47/366 (12.8) 90/724 (12.4)
   Monthly angina 138/358 (38.5) 145/366 (39.6) 283/724 (39.1)
   No angina 177/358 (49.4) 174/366 (47.5) 351/724 (48.5)
Canadian Cardiovascular Society angina class — no./total no. (%)§
 I 72/388 (18.6) 83/388 (21.4) 155/776 (20.0)
 II 147/388 (37.9) 151/388 (38.9) 298/776 (38.4)
 III 15/388 (3.9) 16/388 (4.1) 31/776 (4.0)
New York Heart Association class — no. (%)
 I 65 (16.8) 71 (18.3) 136 (17.5)
 II 139 (35.8) 139 (35.7) 278 (35.8)
 III 0 1 (03) 1 (01)
Type of stress testing — no./total no. (%)
 Nuclear imaging 234/387 (60.5) 245/388 (63.1) 479/775 (61.8)
 Echocardiography 79/387 (20.4) 73/388 (18.8) 152/775 (19.6)
 Cardiac magnetic resonance imaging 0 1/388 (0.3) 1/775 (0.1)
 Exercise stress test 74/387 (19.1) 69/388 (17.8) 143/775 (18.5)
*

Percentages may not total 100 because of rounding. CABG denotes coronary-artery bypass grafting, GFR glomerular filtration rate, IQR in terquartile range, and PCI percutaneous coronary intervention.

Race was reported by the patient.

On the Seattle Angina Questionnaire, a score of 0 to 60 indicates daily or weekly angina, a score of 61 to 99 monthly angina, and a score of 100 no angina. Data were excluded from four sites (42 patients) because of improper completion of forms. In addition, data were missing for 11 other patients.

§

Canadian Cardiovascular Society classes of angina are I (angina only with strenuous exertion), II (slight limitation of physical activity), III (marked limitation of physical activity), and IV (inability to perform any physical activity without angina); class IV angina was an exclusion criterion for the trial.